Boehringer Ingelheim - Value Through Innovation
Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies with 130 years of experience. Click here to learn more.
Search
BI India joins forces with PPAM and BMC to Stop Rabies
This initiative will adopt a two-pronged approach of vaccination and education.
Boehringer Ingelheim India launches VAXXITEK® HVT + IBD, globally acclaimed single shot poultry vaccine
Boehringer Ingelheim India launches VAXXITEK® HVT + IBD, globally acclaimed single shot poultry vaccine. Click here to find out and learn more information.
Boehringer Ingelheim allocates COVID relief fund to support underserved communities and patients in India
Boehringer Ingelheim is making available a Euro One Million COVID relief fund to support underserved communities and patients in India. Learn more here.
COVID-19 Joining forces against COVID-19
While the challenges posed by the COVID-19 pandemic are massive, so are the good examples of corporate citizenship arising all over the world. Learn more.
Boehringer Ingelheim India to sustain growth momentum in 2021, focuses on partnerships in NCD management
Boehringer Ingelheim India to sustain growth momentum in 2021, focuses on partnerships in NCD management. Click here to find out more information.
More Potential
Continuing a journey that began more than 135 years ago, Boehringer Ingelheim steps up its commitment to sustainable development. Find out more here.
Boehringer Ingelheim India and Vvaan Lifesciences Pvt Ltd announce strategic distribution partnership to expand pet portfolio reach.
Boehringer Ingelheim India and Vvaan Lifesciences Pvt Ltd announce strategic distribution partnership to expand pet portfolio reach.
Boehringer Ingelheim & Fighting COVID-19 | Boehringer Ingelheim
Learn how Boehringer Ingelheim may not develop human vaccines but is still part of the medical research collective helping to fight this pandemic.
One step further in fighting rabies in Vietnam
A expedition team set off to the Duc Hue District. The purpose? To vaccinate the entire dog and cat population of several villages. Find out more.ral villages.
It is about saving lives Alexis Jaliquias feline blood bank
Veterinarian Alexis Jaliquias founded one of the first blood banks for cats in South America. Click here to read about this story and find out more.
COVID-19 Boehringer Ingelheim Thailand equips frontline
Boehringer Ingelheim Thailand is working together with the Thai Department of Disease Control during the pandemic. Click here to learn more.
Pet industry trends Millennials
Millennials are now shaping pet markets and facing new issues in pet healthcare. Click here to read and learn more about this new generation of pet owners.
pet care digital age
Pets can be family members, trusted companions – and they are also part of a large global industry. Learn more about pet care in the digital age here.
Watch out: the tick season is there!
From a Southern tick species spreading throughout Europe to the fact American pop singer Justin Bieber is battling Lyme disease, ticks are in the news.
Boehringer Ingelheim receives ad-interim injunctions against four more domestic pharma companies for patent infringement of its anti-diabetes drug
Boehringer Ingelheim receives ad-interim injunctions against four more domestic pharma companies for patent infringement of its anti-diabetes drug.
Boehringer Ingelheim launches additional heart failure indication for Jardiance® (empagliflozin) in India
Boehringer Ingelheim launches additional heart failure indication for Jardiance® (empagliflozin) in India. Click here to find out and learn more.
EMPEROR-Preserved trial reveals that Empagliflozin reduces the risk of hospitalization for heart-failure and cardiovascular death
EMPEROR-Preserved trial reveals that Empagliflozin reduces the risk of hospitalisation for heart-failure and cardiovascular death. Find out more here.
Boehringer Ingelheim India’s stroke awareness campaign enters the GUINNESS WORLD RECORDS™
Boehringer Ingelheim India’s stroke awareness campaign enters the GUINNESS WORLD RECORDS™. Click here to read the press release and find out more.
Boehringer Ingelheim India signs MoU with the Government of Maharashtra, to strengthen stroke care in the state
Boehringer Ingelheim India signs MoU with the Government of Maharashtra, to strengthen stroke care in the state
We are independent, family-owned
At Boehringer Ingelheim we are independent, family-owned and intend to remain so. Click here to discover how we live our Leitbild and learn more.
Boehringer Ingelheim introduces NexGard SPECTRA® for dogs in India
Boehringer Ingelheim introduces NexGard SPECTRA® for dogs in India
Boehringer Ingelheim India recognized as Top Employer 2024
Boehringer Ingelheim India recognized as Top Employer 2024
Boehringer Ingelheim and IIT Kanpur join hands for social impact
Boehringer Ingelheim India to support Lenek Technologies, a startup incubated at SIIC, IIT Kanpur to improve tuberculosis screening through its innovative handheld X-ray device.
COVID-19 Pandemic support in Vietnam
Find out how Boehringer Ingelheim Vietnam is joining hands with the government and hospitals. Click here to find out and learn more information.